Founder of Foghorn Therapeutics, Inc., Cigall Kadoch is on the board of Harvard University, Massachusetts Institute of Technology and Foghorn Therapeutics, Inc. and Associate Professor at Dana-Farber Cancer Institute, Inc. and Assistant Professor at Harvard Medical School.

Dr. Kadoch received a doctorate from Stanford University School of Medicine and an undergraduate degree from the University of California, Berkeley.